Dermata Therapeutics

About:

Dermata is a biotechnology company that focuses on making major advancements in the treatment of serious diseases treated by dermatologists.

Website: http://www.dermatarx.com

Top Investors: Silicon Valley Bank

Description:

Dermata is a development-stage biotechnology company that focuses on making major advancements in the treatment of serious diseases treated by dermatologists. Its business strategy is to identify and develop innovative products that move into clinical trials to demonstrate efficacy and safety in a variety of diseases. They currently exploring the use of a unique botanical product with multiple proposed mechanisms of action in order to treat acne. It was founded in 2014 and headquartered in Encinitas, California.

Total Funding Amount:

$28.5M

Estimated Revenue Range:

$10B+

Headquarters Location:

Encinitas, California, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)dermatarx.com

Founders:

David Hale, Gerald Proehl

Number of Employees:

1-10

Last Funding Date:

2024-09-16

IPO Status:

Public

Industries:

© 2025 bioDAO.ai